Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29279306 | 1.00 | LMNA (0.40) | LMNATHRBCA2 | |
| SCHEMBL394636 | 1.00 | LMNA (0.40) | LMNATHRBCA2 | |
| SCHEMBL29279295 | 1.00 | LMNA (0.40) | LMNATHRBCA2 | |
| SCHEMBL394686 | 1.00 | LMNA (0.40) | LMNATHRBCA2 | |
| SCHEMBL899793 | 1.00 | LMNA (0.40) | LMNATHRBCA2 | |
| SCHEMBL394883 | 1.00 | LMNA (0.40) | LMNATHRBCA2 | |
| SCHEMBL4359264 | 1.00 | LMNA (0.40) | LMNATHRBCA2 | |
| SCHEMBL397273 | 1.00 | LMNA (0.40) | LMNATHRBCA2 | |
| SCHEMBL344485 | 1.00 | LMNA (0.40) | LMNATHRBCA2 | |
| SCHEMBL29140132 | 1.00 | LMNA (0.40) | LMNATHRBCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111763704-A | Method for improving yield and thallus density of semaglutide precursor | 济南康和医药科技有限公司 | 2020-10-13 | — | — | CN | claimed |
| CN-111763704-A | Method for improving yield and thallus density of semaglutide precursor | 济南康和医药科技有限公司 | 2020-10-13 | — | — | CN | disclosed |
| EP-1307236-A2 | USE OF METAL COMPLEXES CONTAINING PERFLUOROALKYL AS CONTRAST AGENTS IN MR-IMAGING FOR THE REPRESENTATION OF PLAQUES, TUMOURS AND NECROSES | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-05-07 | — | — | EP | disclosed |
| WO-2002013874-A2 | USE OF METAL COMPLEXES CONTAINING PERFLUOROALKYL AS CONTRAST AGENTS IN MR-IMAGING FOR THE REPRESENTATION OF PLAQUES, TUMOURS AND NECROSES | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-02-21 | — | — | WO | disclosed |